Fertility clinic marketing sits in a market where commercial urgency and patient vulnerability coexist. Patients compare price, success rates, location, treatment options and emotional support while regulators expect claims to be accurate, contextualised and fair. The strongest 2026 digital strategy makes the clinic easier to compare without oversimplifying treatment outcomes.
WLW FUTURE reviewed the ASA’s December 2025 fertility enforcement report, current HFEA clinic data and 2026 statements, CMA consumer guidance and current HFEA commentary on virtual fertility services. The central opportunity is to build a customer journey which gives people enough information to choose confidently before asking them to invest financially and emotionally.
9,340paid Google and Meta fertility ads reviewed by ASA monitoring
2,380unique ads from more than 60 clinics flagged for expert assessment
80misleading ads identified across 14 advertisers during the project
96.7%compliance reached by October 2025 after enforcement activity
Research boundary
The ASA figures cover paid Google and Meta fertility treatment advertising monitored between September 2024 and October 2025. They are evidence of advertising compliance patterns, not a measure of total UK fertility marketing activity.
The ASA figures cover paid Google and Meta fertility treatment advertising monitored between September 2024 and October 2025. They are evidence of advertising compliance patterns, not a measure of total UK fertility marketing activity.
The headline findings for fertility clinic marketing in 2026
AI monitoring has materially improved compliance
ASA reported that non compliant paid fertility ads fell from 18.1% at the start of monitoring to 3.3% in October 2025, taking overall compliance to 96.7%.
Success rates need context, not a trophy headline
ASA identified unclear or incomplete success rate figures and unsubstantiated best or leading claims. HFEA warns that comparing clinics solely on success rates is difficult because patient mix changes outcomes.
Price is a customer journey issue
CMA guidance says clinics should not use misleadingly low headline prices which omit essential or likely treatment costs. Patients need meaningful cost information early enough to compare options.
Add-ons require evidence and transparency
HFEA said in June 2026 that none of the treatment add-ons it has reviewed indicate an increased chance of having a baby for most fertility patients.
Where treatment happens must be clear
Consumer guidance says clinics should explain if parts of treatment take place at another location or through a partner clinic.
Virtual fertility services create new trust questions
HFEA told the House of Lords in June 2026 that some virtual services can give patients a misleading impression that the whole service is HFEA regulated when licensed treatment happens elsewhere.
ASA monitoring shows the issues regulators are finding at scale
ASA’s December 2025 report reviewed 9,340 paid Google and Meta ads published between September 2024 and October 2025. Its AI based Active Ad Monitoring system flagged 2,380 unique ads from more than 60 clinics for expert review. The ASA identified misleading claims in 80 ads from 14 advertisers, including unsubstantiated best or leading claims and incomplete success rate information. ASA enforcement report
The strongest improvement came from direct monitoring and intervention
After compliance action, 13 clinics amended or removed problematic ads and one was referred to Meta for enforcement.
Success rate marketing needs data context and patient relevance
HFEA’s Choose a Fertility Clinic service was updated in January 2026 with treatment, pregnancy and birth data covering January 2022 to December 2024. HFEA describes it as the place where patients can compare verified data across licensed UK clinics alongside inspection reports, treatments, opening hours and patient ratings. HFEA January 2026
HFEA also tells patients that success rates should be used as a rough guide rather than a prediction and that differences can reflect patient mix and chance. Marketing which selects the strongest percentage without age, denominator, time period or treatment context can make comparison harder rather than easier. HFEA clinic comparison guidance
Interactive fertility marketing risk checker
Check the claim, pricing, treatment and clinic structure together
Choose the closest options. This is a marketing screening tool based on the public sources reviewed for this report.
1. What is the headline claim?
2. How is price presented?
3. Are add-ons promoted?
4. Is treatment location and regulation clear?
Lower risk starting point
Keep claims, costs and clinic structure transparent
A service led journey with useful pricing, no unsupported add-on claims and clear clinic regulation has a more manageable starting position.
Fertility pricing needs to reflect the real treatment pathway
CMA consumer guidance says clinics should not advertise misleadingly low headline prices which omit essential or likely elements of treatment. It also says people need key information at the right time so they can make informed decisions. CMA fertility consumer rights
Explain what the package includes
Separate consultation, scans, blood tests, medication, procedures, storage and likely extras clearly.
Use examples where treatment varies
Patients can understand a range more easily when the variables which change cost are explained.
Make finance supportive
Payment plans should follow transparent treatment information rather than becoming the main sales message.
Treatment add-ons are a trust issue as well as a compliance issue
In June 2026 HFEA responded to new research on fertility add-ons by reiterating that none of the add-ons it has reviewed indicate an increased chance of having a baby for most fertility patients. HFEA says clinics should explain what an add-on involves, the evidence, how likely it is to help, the cost and the relevant HFEA rating. HFEA June 2026
Virtual fertility services need especially clear regulation and location information
In evidence published around a House of Lords debate in June 2026, HFEA said some virtual clinics can give a misleading impression that they are regulated as HFEA clinics even though licensed treatments happen at another provider. It also noted that some virtual services publish their own success rates despite not being licensed clinics. HFEA June 2026
The strongest fertility customer journey helps patients compare before they commit
1. ResearchThe patient compares treatment, location, pricing, success data, reviews and clinic regulation.
2. ShortlistClear clinician information, opening hours, support and realistic outcomes build confidence.
3. ConsultationEligibility, diagnosis, likely treatment options and individual chances are discussed in context.
4. Costed planThe patient receives a clear treatment plan covering expected cost, medication, add-ons and likely extras.
5. Treatment and supportCounselling, communication, monitoring and aftercare continue beyond the initial purchase decision.
Benchmark your current fertility marketing
Current benchmark score
0/10
Start with claims and patient information
Connect success rates, pricing, add-ons, clinic regulation, patient support and conversion measurement before scaling acquisition.
Where compliant fertility growth remains
Own treatment questions
Build useful content around eligibility, IVF, ICSI, donor treatment, timelines, cost and success data.
Win local clinic search
Connect location, treatment availability, opening hours, clinicians and HFEA data.
Turn transparency into differentiation
Clear cost, realistic success information and evidence can make the clinic easier to trust.
Make support part of the proposition
Counselling, coordination and communication can matter as much as the laboratory technology.
Measure qualified patient journeys
Track consultation attendance, treatment start and patient value rather than enquiry volume alone.
Build AI citation readiness
Use HFEA linked data, clinician reviewed explanations and structured treatment content.
WLW FUTURE fertility clinic digital opportunity review
See where your fertility marketing is exposed and where it can grow
WLW FUTURE can review your clinic website, search and AI visibility, success rate claims, pricing, paid media, treatment journeys, competitor position and conversion performance together.
Request a fertility clinic digital opportunity reviewFrequently asked questions
Can fertility clinics advertise success rates?
Yes, but success rate claims need clear context and must not mislead. HFEA also warns that clinic comparisons are difficult because patient mix affects results.
Can a clinic say it is the best or leading fertility clinic?
Superiority claims need substantiation. ASA’s monitoring identified unsubstantiated best and leading claims among misleading fertility ads.
Can clinics advertise a low IVF package price?
Clinics should not use a misleadingly low headline price which omits essential or likely treatment costs.
Can fertility clinics claim add-ons improve the chance of having a baby?
HFEA said in June 2026 that none of the add-ons it has reviewed indicate an increased chance of having a baby for most fertility patients.
Are virtual fertility clinics regulated by HFEA?
The position depends on where licensed activities take place. HFEA has warned that some virtual models can give a misleading impression that the whole service is HFEA regulated.
Sources and methodology
- ASA Enforcement Report: misleading claims in paid ads for fertility clinics. Published 11 December 2025.
- ASA: UK fertility clinics achieve high compliance.
- HFEA Choose a Fertility Clinic update. January 2026.
- HFEA Choose a Fertility Clinic.
- HFEA statement on treatment add-ons. June 2026.
- HFEA evidence on fertility regulation and virtual clinics. June 2026.
- CMA fertility treatment consumer rights guidance.
Commercial methodology: The risk checker and benchmark are WLW FUTURE planning tools based on current public evidence. They do not certify legal or HFEA compliance.
